https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(06)68175-0.pdf

Guillain-Barré syndrome

https://thelancet.com/pdfs/journals/lancet/PIIS0140-6736(16)00339-1.pdf

Guillain-Barré syndrome.

During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypox in the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.

https://science.sciencemag.org/content/sci/302/5650/1519.full.pdf

Are we ready for pandemic influenza

https://zenodo.org/record/1259431/files/article.pdf

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Background The number of reports of influenza-vaccine–associated Guillain–Barre syndrome to the national Vaccine Adverse Event Reporting System increased from 37 in 1992–1993 to 74 in 1993–1994, arousing concern about a possible increase in vaccine-associated risk. Methods Patients given a diagnosis of the Guillain–Barre syndrome in the 1992–1993 and 1993–1994 influenza-vaccination seasons were identified in the hospital-discharge data bases of four states. Vaccination histories were obtained by telephone interviews during 1995–1996 and were confirmed by the vaccine providers. Disease with an onset within six weeks after vaccination was defined as vaccine-associated. Vaccine coverage in the population was measured through a random-digit–dialing telephone survey. Results We interviewed 180 of 273 adults with the Guillain–Barre syndrome; 15 declined to participate, and the remaining 78 could not be contacted. The vaccine providers confirmed influenza vaccination in the six weeks before the onset of Guillain...

/pdf/the-guillain-barre-syndrome-and-the-1992-1993-and-1993-1994-22rbgpgsmx.pdf

The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines

An increased incidence of Guillain-Barre syndrome (polyradiculoneuritis) occurred in individuals who received the A/New Jersey (swine) influenza vaccine in 1976-1977. A retrospective study encompassing the years 1980-1988 was conducted to determine if the US Army's mass influenza vaccination program has been associated with an increased incidence of Guillain-Barre syndrome in active duty soldiers during the study years. No temporally related increase in Guillain-Barre syndrome was found during the study years.

Lorrin Pang

Papers

Guillain-Barré Syndrome and Influenza Vaccination in the US Army, 1980–1988